🇺🇸 FDA
Patent

US 9833450

Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

granted A61KA61K31/343A61K31/496

Quick answer

US patent 9833450 (Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders) held by Lixte Biotechnology, Inc. expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/343, A61K31/496